SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Rubrik, Inc. engages in the provision of cloud data management solutions. Its solutions include backup and recovery, VM backup, Microsoft 365, ransom ware recovery, database backup, cloud solutions, and Polaris sonar. Rubrik products include data protection, data threat analytics, data security posture and cyber recovery. The company was founded by Bipul Sinha, Arvind Jain, Soham Mazumdar, and Arvind Nithrakashyap in December 2013 and is headquartered in Palo Alto, CA.

Rubrik Inc. - Ordinary Shares - Class A

Rubrik Inc. - Class A

Rubrik is trending following its strategic acquisition of AI startup Predibase, a move investors view as a visionary step to bolster its enterprise data security and AI-driven recovery capabilities. Community sentiment remains highly optimistic about the company's long-term potential as a leader in cyber resilience, with many traders focusing on its technical breakout potential despite broader volatility in the software sector.

Unusual Machines, Inc. is a development stage technology company, which engages in the provision of drone solutions with a focus on first-person view (FPV) technology. It offers products to entertainment, recreation, and competitive racing industries. The company was founded on July 11, 2019, and is headquartered in Orlando, FL.

Unusual Machines Inc

Unusual Machines is surging due to intense speculation surrounding potential U.S. government funding for domestic drone manufacturing and strategic ties to high-profile political figures. While the stock has seen significant volatility, the community is focused on supply chain expansion, potential M&A activity, and the sector's long-term role in national defense infrastructure.

ETF Opportunities Trust - Roundhill T-REX 2X Long DRAM Daily Target ETF

T-REX 2X Long DRAM Daily Target ETF

The RAM ETF is trending due to its debut as a 2X leveraged product targeting the memory sector, with participants intensely debating whether it serves as a high-reward momentum play or a dangerous instrument prone to volatility decay. Community discourse is heavily split between those aggressively adding to positions on dips to capture the AI-driven memory supercycle and critics warning that the rapid decline since its launch confirms the risks of using leverage in a volatile market.

Themes ETF Trust - Leverage Shares 2X Long SPCX Daily ETF

Leverage Shares 2x Long SPCX Daily ETF

The community is actively debating the volatility of 2x leveraged SpaceX ETFs like SPCH, with many traders focusing on aggressive scalp strategies to navigate the stock's unpredictable swings. While some participants are eyeing technical breakouts and potential index-related catalysts, others caution that these instruments are better suited for short-term active trading rather than long-term holds due to risks from share lockup expirations and decay.

Select Sector SPDR Trust (The) - State Street Financial Select Sector SPDR ETF

Financial Select Sector SPDR Fund

The financial sector is seeing increased institutional rotation and volatility as investors weigh the impact of persistent inflation and evolving credit conditions. Community sentiment is mixed, with some traders actively rotating into bank stocks to capitalize on technical breakouts, while others are bracing for potential liquidity risks associated with private credit and sector-wide weakness.

Palo Alto Networks, Inc. engages in the provision of network security solutions to enterprises, service providers, and government entities. It operates through the following geographical segments: the United States, Israel, and Other Countries. The company was founded by Nir Zuk in March 2005 and is headquartered in Santa Clara, CA.

Palo Alto Networks Inc

Palo Alto Networks is seeing heavy retail and institutional engagement as investors weigh strong earnings and raised guidance against concerns over high valuation and integration risks following recent acquisitions. The community is actively debating whether the stock's recent parabolic rally into earnings is sustainable or if it is poised for a significant consolidation.

Chip

CHIP is trending as investors debate its potential as a governance token for the USD.AI protocol, which provides GPU-backed financing for AI infrastructure. The community is sharply divided between those highlighting its real-world utility and growth in lending volume and others dismissing it as a high-volatility pump-and-dump scheme.

Enovix Corp. engages in the design and development of silicon-anode lithium-ion batteries. The firm's proprietary 3D cell architecture increases energy density and maintains a high cycle life. It is also developing its 3D cell technology and production process for the electric vehicle and energy storage markets to help enable utilization of renewable energy. The company was founded by Mr. Harrold Jones Rust, III, Ashok Lahiri, and Murali Ramasubramanian in November 2006 and is headquartered in Fremont, CA.

Enovix Corporation

Enovix Corp

Enovix is currently trending as shareholders analyze the company's progress in scaling production for its silicon-anode battery technology, with the community actively debating whether recent production updates for smart eyewear and defense applications signal a long-term turnaround or further delays. While some investors view the current price action as a strategic accumulation opportunity driven by potential industry adoption in the AI-edge and wearable sectors, others remain cautious, highlighting historical volatility and lingering concerns over manufacturing timelines.

Aave is a decentralized money market protocol where users can lend and borrow cryptocurrency across 20 different assets as collateral. The protocol has a native token called AAVE, which is also a governance token that lets the community decide the direction of the protocol in a collective manner. Lenders can&nbsp;earn interest by providing liquidity to the market, while borrowers can borrow by collateralizing their cryptoassets to take out loans from the liquidity pools.

AAVE

Aave is currently drawing significant community attention as investors debate its potential for long-term growth versus short-term volatility, with many highlighting its role as a leading DeFi protocol. Discussions are centered on institutional integration prospects, the impact of the V4 protocol upgrade, and favorable comparisons to competitors like Compound.

Themes ETF Trust - Leverage Shares 2X Short SPCX Daily ETF

Leverage Shares 2x Short SPCX Daily ETF 

SSPC is experiencing high trading volume and volatility as retail investors utilize the ETF to gain leveraged exposure to a potential pullback in the underlying SpaceX stock. Community discussions are heavily focused on navigating upcoming lockup expirations and sector-wide sentiment, with traders actively debating short-term entry points versus long-term valuation concerns.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$ITRM FUK! I’m calling it-yellowjacker is correct- it’ll be Shionogi(IMO)

WHAT cUTI STEP-DOWN APPROVAL IS WORTH TO SHIONOGI

THE INVESTMENT REQUIRED

Based on everything established in this conversation — the existing 5,000 patient database, the 86.8% vs 66.4% IV-to-oral step-down rate already demonstrated in Phase 3, and the FDA meeting goal date already set for January 2026 — Shionogi would not be starting from zero. They would be running a focused bridging study designed to address the specific technical ASB endpoint issue that caused the original CRL, not a full new pivotal trial.

Realistic cost to Shionogi of getting cUTI step-down approved:

Trial design and FDA Type B/C meeting: $2-3M
Focused bridging study (300-600 patients, shorter than original trial): $15-20M
Data analysis, NDA supplement preparation: $3-5M
FDA PDUFA user fees and regulatory costs: $2-3M
Total investment: $22-31M

ALAS

Mr.Yoda

James Bond

WindowShopper

Alex Bailey

Swedishviking1

StockTwits for iOS

Iterum Therapeutics Plc

 FUK! I’m calling it-yellowjacker is correct- it’ll be Shionogi(IMO)

WHAT cUTI STEP-DOWN APPROVAL IS WORTH TO SHIONOGI

THE INVESTMENT REQUIRED

Based on everything established in this conversation — the existing 5,000 patient database, the 86.8% vs 66.4% IV-to-oral step-down rate already demonstrated in Phase 3, and the FDA meeting goal date already set for January 2026 — Shionogi would not be starting from zero. They would be running a focused bridging study designed to address the specific technical ASB endpoint issue that caused the original CRL, not a full new pivotal trial.

Realistic cost to Shionogi of getting cUTI step-down approved:

Trial design and FDA Type B/C meeting: $2-3M
Focused bridging study (300-600 patients, shorter than original trial): $15-20M
Data analysis, NDA supplement preparation: $3-5M
FDA PDUFA user fees and regulatory costs: $2-3M
Total investment: $22-31M